At the 29th Conference of the Parties to the UN Framework Convention on Climate Change (COP29), representatives of the International Public Movement ALLATRA made a significant contribution to the international dialogue on climate change.
In “Buddy Moon: Lisa & Tom (City of Grove)”, author Rhonda Boehm delivers an engaging romance set against the idyllic backdrop of Hawaii. The story follows two people from vastly different worlds, each on their journey of healing and self-acceptance, as they attempt to open their hearts to love while grappling with their pasts.
GPN Vaccines Ltd is pleased to announce that dose escalation has been approved and dosing of the second cohort has commenced in its Phase 1 clinical trial of Gamma-PN vaccine in older adults.
AGIS' C5ISR combined Air and Ground C5ISR System fulfills the need for an integrated, All-Domain, C5ISR combined arms capability that can seamlessly operate either as an independent Air and Ground system or can function as an integrated Air and Ground C5ISR System capable of simultaneously performing both Air and Ground functions.
Entegrion, Inc., a leading developer of innovative solutions for clinical diagnosis and management of hemostasis, highlighted a newly presented study demonstrating the clinical value of its portable Viscoelastic Coagulation Monitor (VCM) in a safety analysis of Anti-Xa and the VCM.
GenieUs Genomics (“GenieUs”) is excited to provide advanced genomic analysis for Neurizon Therapeutics Limited’s (“Neurizon”; ASX:NUZ; ASX:NUZOA) Phase 1 clinical trial of monepantel, now known as NUZ-001, marking an important step in understanding the genetic landscape of ALS patients.
“From Fear to Peace” is more than just a self-help guide; it’s a practical toolkit designed to help readers navigate life’s toughest challenges with clarity and calm.
